By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Genenta Science S.p.A.

Genenta Science S.p.A. (GNTA)

NASDAQ Market Data in USD, Fundamentals in EUR
$2.75
-$0.68
-19.83%
Last Update: 11 Sept 2025, 20:00
$50.30M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$2.56 - $7.28
52 Week Range

GNTA Stock Price Chart

Explore Genenta Science S.p.A. interactive price chart. Choose custom timeframes to analyze GNTA price movements and trends.

GNTA Company Profile

Discover essential business fundamentals and corporate details for Genenta Science S.p.A. (GNTA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

15 Dec 2021

Employees

13.00

CEO

Pierluigi Paracchi

Description

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. The company was incorporated in 2014 and is headquartered in Milan, Italy.

GNTA Financial Timeline

Browse a chronological timeline of Genenta Science S.p.A. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 28 Mar 2025

Earnings released on 30 Jun 2024

EPS came in at -$0.24 .

Earnings released on 24 Apr 2024

EPS came in at -$0.30 surpassing the estimated -$0.42 by +29.66%, while revenue for the quarter reached $5.52M .

Earnings released on 30 Jun 2023

EPS came in at -$0.40 surpassing the estimated -$0.41 by +3.25%.

Earnings released on 26 Apr 2023

EPS came in at -$0.38 .

Earnings released on 7 Oct 2022

EPS came in at -$0.12 .

Earnings released on 4 May 2022

EPS came in at -$0.11 .

Earnings released on 15 Dec 2021

EPS came in at -$0.33 .

Earnings released on 31 Dec 2020

EPS came in at -$0.26 .

GNTA Stock Performance

Access detailed GNTA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run